Skip to content
Vinorelbine
Navelbine (vinorelbine) is a small molecule pharmaceutical. Vinorelbine was first approved as Navelbine on 1994-12-23. It is used to treat breast neoplasms, hodgkin disease, non-small-cell lung carcinoma, and ovarian neoplasms in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
neoplasmsD009369
respiratory tract diseasesD012140
urogenital diseasesD000091642
hemic and lymphatic diseasesD006425
skin and connective tissue diseasesD017437
endocrine system diseasesD004700
immune system diseasesD007154
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Vinorelbine tartrate
Tradename
Company
Number
Date
Products
NAVELBINELaboratoires Pierre FabreN-020388 DISCN1994-12-23
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
vinorelbineANDA2022-05-31
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
breast neoplasmsEFO_0003869D001943C50
hodgkin diseaseD006689C81
non-small-cell lung carcinomaD002289
ovarian neoplasmsEFO_0003893D010051C56
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
L: Antineoplastic and immunomodulating agents
L01: Antineoplastic agents
L01C: Plant alkaloids and other natural products, antineoplastic drugs
L01CA: Vinca alkaloids and analogues, antineoplastic
L01CA04: Vinorelbine
HCPCS
Code
Description
J9390
Injection, vinorelbine tartrate, 10 mg
Clinical
Clinical Trials
898 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Precursor cell lymphoblastic leukemia-lymphomaD054198C91.0457536198163
Large b-cell lymphoma diffuseD016403C83.33048182180
Non-hodgkin lymphomaD008228C85.91927101252
Follicular lymphomaD008224C8213128126
Mantle-cell lymphomaD020522C83.16134120
Burkitt lymphomaD002051C83.71010219
NeoplasmsD009369C80941114
Large-cell lymphoma anaplasticD017728C84.654119
Wilms tumorD00939623217
Enteropathy-associated t-cell lymphomaD058527C86.21314
Show 2 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223C85.92299519170
LeukemiaD007938C9593930577
NeuroblastomaD009447EFO_0000621121913347
Central nervous system neoplasmsD01654361813541
SarcomaD01250951710234
Hodgkin diseaseD006689C8141214129
T-cell lymphoma peripheralD016411C84.968518
B-cell lymphomaD016393118318
RetinoblastomaD012175393216
MedulloblastomaD00852738515
Show 44 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Biphenotypic leukemia acuteD015456C95.0357
Myelodysplastic syndromesD009190D46425
Precursor t-cell lymphoblastic leukemia-lymphomaD054218435
Bcr-abl positive chronic myelogenous leukemiaD015464EFO_0000340235
Plasmablastic lymphomaD000069293C83.3424
B-cell lymphoma marginal zoneD018442C88.4234
Primary effusion lymphomaD054685C83.8333
Ovarian neoplasmsD010051EFO_0003893C56123
Myeloid leukemia chronic-phaseD01546622
Adult t-cell leukemia-lymphomaD015459C91.5212
Show 40 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Lymphoid leukemiaD007945C9122
HypersensitivityD006967EFO_0003785T78.4011
PinealomaD01087111
Neoplasm metastasisD009362EFO_000970811
Deltaretrovirus infectionsD006800EFO_100130311
SyndromeD01357711
Composite lymphomaD05861711
Hematologic diseasesD006402EFO_0005803D75.911
MelanomaD00854511
RecurrenceD01200811
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
VomitingD014839HP_0002013R11.122
NauseaD009325HP_0002018R11.011
Ataxia telangiectasiaD001260Orphanet_100G11.311
OtotoxicityD00008101511
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameVINORELBINE
INNvinorelbine
Description
Vinorelbine (NVB), sold under the brand name Navelbine among others, is a chemotherapy medication used to treat a number of types of cancer. This includes breast cancer and non-small cell lung cancer. It is given by injection into a vein or by mouth.
Classification
Small molecule
Drug classvinca alkaloids
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2
Identifiers
PDB
CAS-ID71486-22-1
RxCUI39541
ChEMBL IDCHEMBL553025
ChEBI ID480999
PubChem CID60780
DrugBankDB00361
UNII IDQ6C979R91Y (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 14,447 documents
View more details
Safety
Black-box Warning
Black-box warning for: Vinorelbine
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
64,083 adverse events reported
View more details